Ukraine.UroWeb.ru — Український інформаційний портал урологів
(Украинский информационный портал урологов)

Навигация
Главная
О проекте
О нас
Контакты
Журналы
ЛОКЛ
Новости
Конференции и симпозиумы
Профсоюзы
Реформы и предложения
Обращения
Обучение
Библиотека
Лекции
Нормативные документы
Производители
Ссылки
Наши партнеры

Информация для пациентов

Консультации уролога
Форум
Поиск

Ассоциация урологов Украины
Сайт Института урологии Академии медицинских наук Украины
Европейская Ассоциация Урологов
UroWeb.ru - Урологический информационный портал
Explorer.UroWeb.ru — исследователь урологии
Авторизация


 
Главная arrow Новости arrow Full Review of the 20th European Hematology Association Congress
Full Review of the 20th European Hematology Association Congress Версия для печати Отправить на e-mail
02.08.2015
 

_________________________________________________________

 

Dear Shulyak Alexandr, 

 

Welcome to this edition of EMJ Hematology, which brings you unrelenting coverage of this year’s premiere European haematological event: the 20th European Hematology Association (EHA) Congress, which took place in Vienna, Austria on 11th-14th June. Following a thrilling and momentous four days, our team returned home in great spirits, having witnessed an abundance of new findings, discussions, and debates that covered a mass of haematological subjects during the anniversary congress. Inside we have compiled a series of abstract reviews, highlights of presentations, interviews with key members of the haematological community, and in-depth symposium reviews straight from the congress floor, which will enable our readers to discover many of the vital recent developments from this field of medicine. 

 

 

 

New treatment options were a key theme of EHA 2015 and great strides have taken place, demonstrated in a series of presentations for conditions such as acute lymphoblastic leukaemia, myelofibrosis, chronic myeloid leukaemia, and multiple myeloma. Inside we have included a series of intriguing articles, discussing areas such as relapsed/refractory multiple myeloma, thrombosis in haematological disorders, mantle cell lymphoma, and the potential of biosimilars to improve patient access in haematology. Our congress review features details of the event’s most exciting presentations. These include an Australian study which provides evidence that a combination of two targeted therapies, venetoclax and rituximab, is a safe and effective therapy for chronic lymphocytic leukaemia, as well as research suggesting that pacritinib, an oral next-generation multikinase inhibitor, significantly improves the disease symptoms and quality of life of myelofibrosis patients.

 

 

What's included in this edition of EMJ Hematology?

 

 

 

Editorial Board

 

Congress Review

Review of the 20th Congress of the European Hematology Association held in Vienna, Austria, 11th-14th June 2015 

 

Interviews with EMJ Hematology Editorial Board and Authors

 

Symposium Reviews

 

 

Abstract Reviews

 

Article

Get Involved
 

Previously this year we published EMJ Oncology, available on our website, which included top-quality manuscripts covering hot topics in oncology and haematology. We hope that this edition of EMJ Hematology will prove to be an enlightening read for our audience, and we are greatly looking forward to the European Cancer Congress (ECC) on 25th-29th September, which will provide further updates in haematology. If you would like to take part in our online discussion forum, please feel free to take advantage of our social media channels including Facebook, LinkedIn, and YouTube. 

 

Warm regards,

 

Zoë Webster

Head of Publishing

Последнее обновление ( 19.08.2015 )
 
< Пред.   След. >
Ukraine.UroWeb.ru - Український інформаційний портал урологів (Украинский информационный портал урологов) © 2020